|Anterior chamber bleeding after laser peripheral iridotomy.|
|PMID: 23538479 Owner: NLM Status: MEDLINE|
|IMPORTANCE: To our knowledge, this is the first study to describe the correlation of anterior chamber bleeding after laser peripheral iridotomy (LPI) and antiplatelet therapy.
OBJECTIVE: To determine the incidence and amount of anterior chamber bleeding after laser peripheral iridotomy in patients whose condition is suggestive of primary angle-closure glaucoma (PACS) who continued their antiplatelet or anticoagulant treatment before undergoing LPI compared with when they discontinued treatment.
DESIGN AND SETTING: A prospective controlled trial.
PATIENTS: Patients with suspected bilateral primary angle-closure and no other ocular disease who take antiplatelet or anticoagulant medications regularly (from January 2010-October 2011) were enrolled.
MAIN OUTCOME AND MEASURE: The incidence of anterior chamber bleeding with and without antiplatelet and anticoagulant therapy.
RESULTS: A total of 104 patients (208 eyes) participated in the study. Thirty-six eyes (34.6%) in the treated and untreated arms bled. The amount of bleeding did not differ significantly when the patient was on or off antiplatelet or anticoagulant treatment, nor did the immediate postprocedure mean intraocular pressure (P = .13). The type of antiplatelet or anticoagulant, total laser energy, age, sex, or color of irides were not risk factors for increased bleeding (P = .156 for all parameters).
CONCLUSIONS: No indication was noted for discontinuing these medications before a high-powered pulsed laser peripheral iridotomy.
|Shani Golan; Hani Levkovitch-Verbin; Gabi Shemesh; Shimon Kurtz|
Related Documents :
|23591829 - Safety of artemisinin-based combination therapies in nigeria: a cohort event monitoring...
23576939 - Idiopathic toe walking: to treat or not to treat, that is the question.
17367059 - Prognostic value of the lateral spread response for intraoperative electromyography mon...
23651609 - Real-life compliance and persistence among users of subcutaneous and sublingual allerge...
16988499 - Local perfusion of the tumor necrosis factor alpha blocker infliximab to the inner ear ...
23758689 - Cerebral microdialysis reflects the neuroprotective effect of fractionated plasma separ...
3525049 - Endoscopic sclerotherapy for esophageal varices.
9704829 - Influence of an antiperspirant on foot blister incidence during cross-country hiking.
1316259 - Prevention of deep vein thrombosis in orthopaedic surgery. comparison of two different ...
|Type: Controlled Clinical Trial; Journal Article|
|Title: JAMA ophthalmology Volume: 131 ISSN: 2168-6173 ISO Abbreviation: JAMA Ophthalmol Publication Date: 2013 May|
|Created Date: 2013-06-07 Completed Date: 2013-07-26 Revised Date: 2013-11-06|
Medline Journal Info:
|Nlm Unique ID: 101589539 Medline TA: JAMA Ophthalmol Country: United States|
|Languages: eng Pagination: 626-9 Citation Subset: AIM; IM|
|Department of Ophthalmology, Tel Aviv Medical Center, Tel Aviv, Israel. email@example.com|
|APA/MLA Format Download EndNote Download BibTex|
Aged, 80 and over
Anterior Chamber / pathology
Anticoagulants / therapeutic use*
Aspirin / therapeutic use
Glaucoma, Angle-Closure / prevention & control*
Hyphema / etiology*
Iris / surgery
Lasers, Solid-State / therapeutic use
Platelet Aggregation Inhibitors / therapeutic use*
Ticlopidine / analogs & derivatives, therapeutic use
Warfarin / therapeutic use
|0/Anticoagulants; 0/Platelet Aggregation Inhibitors; 50-78-2/Aspirin; 55142-85-3/Ticlopidine; 81-81-2/Warfarin; A74586SNO7/clopidogrel|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Line Transect and Triangulation Surveys Provide Reliable Estimates of the Density of Kloss' Gibbons ...
Next Document: Hepatitis B and inflammatory bowel disease: Role of antiviral prophylaxis.